Biofil Chemicals & Pharmaceuticals Limited — Others, 05-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

BIOFIL Chemicals and Pharmaceuticals has announced a board meeting to address matters related to corporate governance and compliance. The update includes a confirmation certificate from Ankit Consultancy, indicating that securities for dematerialization in the quarter ended March 31, 2025, have been processed correctly, ensuring a smooth transition to electronic trading. This efficient handling supports operational integrity and might enhance shareholder confidence. Overall, the proactive approach in compliance reflects a positive outlook for the company, potentially attracting investor interest and reinforcing market credibility.